SEQUA.BR Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 bal. 2024 @ 17:57):

Sequana Medical NV, a commercial stage medical device company, engages in the development of platform for the treatment of fluid overload in liver disease, malignant ascites, and heart failure...

Stats
Dzisiejszy wolumen	45 796.00
Średni wolumen	104 221
Kapitalizacja rynkowa	42.04M
EPS	€0 ( 2023-02-09 )
Następna data zysków	( €0 ) 2024-05-23
Last Dividend	€0 ( N/A )
Next Dividend	€0 ( N/A )
P/E	-1.050
ATR14	€0.0110 (0.79%)

Sequana Medical NV Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Sequana Medical NV Finanse

Annual	2023
Przychody:	€712 000
Zysk brutto:	€-4.15M (-583.43 %)
EPS:	€-1.220

FY	2023
Przychody:	€712 000
Zysk brutto:	€-4.15M (-583.43 %)
EPS:	€-1.220

FY	2022
Przychody:	€922 687
Zysk brutto:	€718 090 (77.83 %)
EPS:	€-1.350

FY	2021
Przychody:	€370 500
Zysk brutto:	€293 837 (79.31 %)
EPS:	€-0.751

Financial Reports:

No articles found.

Sequana Medical NV

Sequana Medical NV, a commercial stage medical device company, engages in the development of platform for the treatment of fluid overload in liver disease, malignant ascites, and heart failure. The company's products include alfapump system, an implantable pump system for the treatment of refractory liver ascites and malignant ascites; Direct Sodium Removal (DSR) for the treatment of persistent congestion due to heart failure; and alfapump DSR, a fully implanted system for direct sodium removal therapy in patients with fluid overload due to heart failure. It operates in Belgium, Germany, France, Switzerland, and internationally. The company was founded in 2006 and is headquartered in Ghent, Belgium.